India-based Ranbaxy Pharmaceuticals, the largest producer of the generic version of Lipitor (atorvastatin), has halted production of the drug. The company, which had voluntarily recalled more than 40 lots of its generic version of the cholesterol lowering drug from the US market in November 2012, after finding batches containing small glass particles, appears to have lost its lead in the generic Lipitor market as a consequence.
展开▼
